Biopharma alliance announced.

Zenith Technologies and GE Healthcare’s Life Sciences business have announced a collaboration to support biopharmaceutical manufacturing deployment.

As part of the partnership, Zenith Technologies’ methodologies, systems and libraries will be offered as a service to GE Healthcare’s clients in bioprocessing. The combined offering is aimed at helping biopharmaceutical manufacturers increase productivity, improve efficiency and reduce costs.

The two companies will integrate process control systems, manufacturing execution system (MES) solutions and other supporting technologies with GE Healthcare’s start-to-finish technologies and solutions for the biopharmaceutical manufacturing industry.

Jan Makela, general manager at BioProcess GE Healthcare said: "The development of our KUBio modular manufacturing facilities and FlexFactory single-use manufacturing platform was fuelled by the need for customers to deploy biopharmaceutical manufacturing capacity more quickly and at a lower cost.

“Implementing these advanced technology platforms requires automation expertise for which we partner with a number of world class companies. With Zenith Technologies’ expertise in automation integration and customer support, we will be able to offer more choice to customers.”

Brendan O’Regan, founder at Zenith Technologies, said: “This is a significant milestone in our development and ushers in a new era of opportunity for both companies.

“GE offers an unprecedented solution to our pharmaceutical customers to help rapidly deploy capacity and significantly reduce time to market. Combined with our manufacturing software systems and on the ground, global support services, we can help biopharmaceutical manufacturers improve their processes and ultimately increase their competitiveness.”

• Headquartered in Cork (IRL) and with 14 offices globally, Zenith Technologies delivers manufacturing software systems that enable life science businesses to be compliant and competitive. The company combines pharmaceutical industry expertise and full life-cycle support, including managed services, with a portfolio of technology application and platform 
experience.

@ZenithIre #PAuto @GE_LifeSciences #PHarma

Collaboration to drive biopharma manufacturing efficiency.

GE Healthcare’s Life Sciences business and Emerson Process Management have announced a collaboration aimed at increasing productivity and improving efficiency in the production of biopharmaceuticals such as monoclonal antibodies and vaccines. 

Collaboration.

The two companies will collaborate to integrate Emerson’s DeltaV™ distributed control system with GE Healthcare’s enterprise offerings and start-to-finish technologies for the global biomanufacturing industry. The first DeltaV-driven GE Healthcare installation, which is expected to be complete before the end of the year, will be a FlexFactory™, GE’s integrated manufacturing platform based on single-use technologies.

Biopharmaceutical manufacturers are increasingly looking to automate production processes, driven by the industry need to increase efficiency and reduce costs. GE’s start-to-finish portfolio of single-use bioprocessing technologies already allows manufacturers to reduce set-up times and increase manufacturing flexibility. Emerson’s DeltaV system, which uses predictive technologies to connect people, processes and production, enables remote monitoring and control from multiple locations across a company’s network and is already widely used in the pharmaceutical industry. The DeltaV system will be offered as an automation control platform for GE’s single-use bioprocessing offerings.

Emmanuel Ligner, Global Commercial Manager, BioProcess, GE Healthcare Life Sciences, said: “Healthcare providers and the biopharmaceutical industry are facing enormous pressures. Emerson and GE share a vision that an integrated and automated approach to manufacturing has the potential to help drive improvements in production efficiency of these life-saving medicines. This collaboration with Emerson, combined with our depth and breadth of expertise in start-to-finish technologies for bioprocessing, promises to bring real benefits to our customers and to healthcare providers worldwide.”

“We believe that the combination of Emerson’s automation technologies and the GE FlexFactory will offer superior process performance, consistency of product, and reduced validation time,” said Jerry Brown, senior vice president of industry solutions for Emerson Process Management.  “This collaboration will support more predictable processes that eliminate unnecessary work, which translates into a reduced time to market for our customers.”

@EmersonProcess @GEHealthcare #PAuto